Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

278 Press Releases
DateTitleCompany
06 Nov 15 Takeda to Present Data from Ixazomib’s Phase 3 Study in Relapsed/Refractory Multiple Myeloma at Upcoming American Society of Hematology Annual Meeting Takeda ,
Published by
PharmiWeb.com
30 Oct 15 Takeda Reports Results for the First Half of FY2015 Confirms Management Guidance for the Full Year Takeda Pharmaceutical Company Limited,
Published by
Business Wire
20 Oct 15 Takeda Presents Vedolizumab Data at the 2015 American College of Gastroenterology (ACG) Annual Meeting Takeda ,
Published by
PharmiWeb.com
14 Oct 15 UCL and Takeda Announce a New Research Partnership to Identify Novel Therapeutic Targets for Neurodegenerative Diseases Takeda Pharmaceutical Company Limited,
Published by
Business Wire
02 Oct 15 Takeda Celebrates Fifth Annual Takeda Cares Day by Expanding Nationwide and Raising More Than $250,000 for Chicagoland Nonprofits Takeda Pharmaceuticals Company Limited,
Published by
PR Newswire
01 Oct 15 Takeda selected for the sixth consecutive year for Dow Jones Sustainability Asia Pacific Index Takeda ,
Published by
PharmiWeb.com
01 Oct 15 New Drug Application Approval in Japan for Copaxone® Subcutaneous Injection 20 mg Syringe, a Drug for the Treatment of Multiple Sclerosis Takeda ,
Published by
PharmiWeb.com
01 Oct 15 Takeda Obtained New Drug Application Approval of Leuplin® PRO for injection kit 22.5 mg in Japan for the Treatment of Prostate Cancer and Premenopausal Breast Cancer Takeda ,
Published by
PharmiWeb.com
01 Oct 15 Takeda Submits a New Drug Application for the Fixed-Dose Combination of Nesina® and Metformin Hydrochloride for the Treatment of Type 2 Diabetes in Japan Takeda ,
Published by
PharmiWeb.com
29 Sep 15 Takeda Selected for the Sixth Consecutive Year for Dow Jones Sustainability Asia Pacific Index Takeda Pharmaceutical Company Limited,
Published by
Business Wire
28 Sep 15 Takeda Pharmaceutical: New Drug Application Approval in Japan for Copaxone® Subcutaneous Injection 20 mg Syringe, a Drug for the Treatment of Multiple Sclerosis Takeda Pharmaceutical Company Limited,
Published by
Business Wire
24 Sep 15 Takeda to Highlight Ixazomib Clinical Development Program at Upcoming International Myeloma Workshop Takeda ,
Published by
PharmiWeb.com
22 Sep 15 Takeda to Highlight Ixazomib Clinical Development Program at Upcoming International Myeloma Workshop Takeda Pharmaceutical Company Limited,
Published by
Business Wire
14 Sep 15 Takeda Joins WIPO Re:Search to Accelerate R&D of New Drugs for Neglected Tropical Diseases, Malaria and TB Takeda Pharmaceutical Company Limited,
Published by
Business Wire
12 Sep 15 More than 96 Percent of Claimants Opt-In to ACTOS Resolution Program; Takeda Expects Resolution to Become Effective Once Submission Review Completed; Takeda Stands Behind ACTOS Takeda Pharmaceuticals,
Published by
PR Newswire
11 Sep 15 Gencia and Takeda Team to Discover and Develop Novel Class of Mitochondrial Therapeutics Takeda ,
Published by
PharmiWeb.com
09 Sep 15 U.S. FDA Grants Priority Review to Takeda’s Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
29 Aug 15 Takeda Announces Appointment of New Senior Leadership Takeda ,
Published by
Pharmiweb.com
31 Jul 15 Takeda reports 1st quarter results of FY2015 with underlying revenue growth of +6.1% Takeda ,
Published by
PharmiWeb.com
31 Jul 15 Takeda Publishes Annual Report 2015 Takeda ,
Published by
PharmiWeb.com
31 Jul 15 Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA Takeda ,
Published by
PharmiWeb.com
21 Aug 15 Takeda Announces European Medicines Agency Acceptance of Ixazomib’s Marketing Authorization Application for Patients with Relapsed/Refractory Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
23 Aug 15 Takeda Announces European Medicines Agency Acceptance of Ixazomib's Marketing Authorization Application for Patients with Relapsed/Refractory Multiple Myeloma Takeda ,
Published by
Pharmiweb.com
21 Aug 15 Takeda Announces European Medicines Agency Acceptance of Ixazomib’s Marketing Authorization Application for Patients with Relapsed/Refractory Multiple Myeloma Takeda Pharmaceuticals,
Published by
FleishmanHillard
26 Aug 15 Takeda and Nanotherapeutics Announce Agreement to Expand Takeda's Commercialization and Technology Access Rights in Support of Influenza and Other Vaccine Programs Takeda Pharmaceutical Company Limited,
Published by
Business Wire
29 Aug 15 Takeda and Nanotherapeutics Announce Agreement to Expand Takeda's Commercialization and Technology Access Rights in Support of Influenza and Other Vaccine Programs Takeda ,
Published by
Pharmiweb.com
27 Jul 15 European Medicines Agency Grants Accelerated Assessment of Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
28 Jul 15 Takeda Included in the FTSE4Good Global Index for the 11th Consecutive Year Takeda ,
Published by
PharmiWeb.com
28 Jul 15 DNDi and Takeda Collaborate for the Lead Optimization for Aminopyrazole Series for Visceral Leishmaniasis Takeda,
Published by
PharmiWeb.com
28 Jul 15 European Medicines Agency Grants Accelerated Assessment of Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma Takeda,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.